Effects of the combination of red yeast rice-containing commercial Chinese polyherbal preparation with statins for dyslipidemia: a systematic review and meta-analysis.

ABSTRACT:

Background

Significant challenges are associated with the pharmacological management of dyslipidemia, an important risk factor for cardiovascular disease. Limited reliable evidence exists regarding the efficacy of red yeast rice (RYR)-containing commercial Chinese polyherbal preparation (CCPP), despite their widespread use in China.

Purpose

We aimed to investigate the efficacy of RYR-containing CCPPs combined with statins in treating dyslipidemia.

Methods

Eight databases were searched for relevant randomized controlled trials (RCTs) from database inception date to November 2023. Outcome measures, including low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C), total cholesterol (TC), triglyceride (TG), clinical efficacy, and adverse

SUBMITTER: Shi M 

PROVIDER: S-EPMC11300347 | biostudies-literature | 2024

REPOSITORIES: biostudies-literature